A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas

Paclitaxel is a powerful chemotherapeutic drug, used for the treatment of many cancer types, including esophageal adenocarcinomas (EAC). Autophagy is a lysosome-dependent degradation process maintaining cellular homeostasis. Defective autophagy has been implicated in cancer biology and therapy resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Olivia, Janser, Félice A., Dislich, Bastian, Berezowska, Sabina, Humbert, Magali, Seiler, Christian A., Kroell, Dino, Slotta-Huspenina, Julia, Feith, Marcus, Ott, Katja, Tschan, Mario P., Langer, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999293/
https://www.ncbi.nlm.nih.gov/pubmed/29897944
http://dx.doi.org/10.1371/journal.pone.0197610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999293/
https://www.ncbi.nlm.nih.gov/pubmed/29897944
http://dx.doi.org/10.1371/journal.pone.0197610

Ejemplares similares